COVID-19 Tied to Increased Risk for Rheumatic Disease
(MedPage Today) -- Rates of new-onset autoimmune inflammatory rheumatic disease (AIRD) such as rheumatoid arthritis and systemic lupus erythematosus were significantly increased following bouts of COVID-19 in South Korea and Japan, researchers... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - March 4, 2024 Category: Infectious Diseases Source Type: news

ALOX5 drives the pyroptosis of CD4+ T cells and tissue inflammation in rheumatoid arthritis | Science Signaling
Leukotriene-induced T cell pyroptosis drives synovial inflammation in rheumatoid arthritis. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - February 27, 2024 Category: Science Source Type: news

Why Is Teva Pharma Stock Trading Higher Today?
Friday, Alvotech ALVO and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd TEVA, announced the FDA approved Simlandi (adalimumab-ryvk) injection, as an interchangeable biosimilar to AbbVie Inc’s ABBV Humira. The biosimilar is indicated for adult rheumatoid arthritis,…#alvotech #tevapharmaceuticals #fda #abbvieincs #abbvhumira #crohn #humira #teva #tevapharma #splitspeculations (Source: Reuters: Health)
Source: Reuters: Health - February 26, 2024 Category: Consumer Health News Source Type: news

New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies
Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed without an allergic reactionThe U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergiesAllergic reactions can be life-threatening and it is estimated that food-related anaphylaxis results in 30,000 medical events treated in emergency rooms in the U.S. each year1-3Basel, 25 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today data from Stage 1 of the N...
Source: Roche Investor Update - February 25, 2024 Category: Pharmaceuticals Source Type: news

New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies
Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed without an allergic reactionThe U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergiesAllergic reactions can be life-threatening and it is estimated that food-related anaphylaxis results in 30,000 medical events treated in emergency rooms in the U.S. each year1-3Basel, 25 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today data from Stage 1 of the N...
Source: Roche Media News - February 25, 2024 Category: Pharmaceuticals Source Type: news

Therapeutic Intervention Feasible for Preventing Rheumatoid Arthritis in Patients at Risk
FRIDAY, Feb. 23, 2024 -- Therapeutic intervention with abatacept is feasible for patients at risk for rheumatoid arthritis, according to a study published online Feb. 13 in The Lancet. Andrew P. Cope, M.D., from King ' s College London, and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 23, 2024 Category: Pharmaceuticals Source Type: news

Another Study Backs Treatment for Preclinical Rheumatoid Arthritis
(MedPage Today) -- Inflammatory markers were reduced in patients with persistent joint pain and other markers for incipient rheumatoid arthritis (RA), as was progression to formal RA diagnosis, after a 6-month course of abatacept (Orencia) in a... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - February 16, 2024 Category: Rheumatology Source Type: news

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placeboMore than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2   Detailed OUtMATCH results will be featured in a late-breaking symposiumat the 2024 AAAAI Annual MeetingBasel, 16  February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food ...
Source: Roche Investor Update - February 16, 2024 Category: Pharmaceuticals Source Type: news

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placeboMore than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2   Detailed OUtMATCH results will be featured in a late-breaking symposiumat the 2024 AAAAI Annual MeetingBasel, 16  February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food ...
Source: Roche Media News - February 16, 2024 Category: Pharmaceuticals Source Type: news

Acupuncture Linked to Lower Incidence of Ischemic Stroke in RA
FRIDAY, Feb. 16, 2024 -- For patients with rheumatoid arthritis (RA), the risk for ischemic stroke is lower for those receiving acupuncture, according to a study published online Feb. 13 in BMJ Open. Chia-Yu Huang, from Taichung Tzu Chi Hospital in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 16, 2024 Category: Pharmaceuticals Source Type: news

Drug Used to Treat Rheumatoid Arthritis May Also Help Prevent It
THURSDAY, Feb. 15, 2024 -- Philip Day loved playing soccer so much that the 35-year-old software engineer founded a website – FootballMatcher.com – to help people connect for pickup games.The fun went on pause when Day developed joint pain so... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 15, 2024 Category: General Medicine Source Type: news

Acupuncture May Lower Stroke Risk in Rheumatoid Arthritis Patients
WEDNESDAY, Feb. 14, 2024 -- Acupuncture may protect people with rheumatoid arthritis (RA) from stroke, new research suggests. The study indicates that a course of acupuncture treatment may lower blood levels of inflammatory proteins called... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 14, 2024 Category: General Medicine Source Type: news

Clinical trial shows rheumatoid arthritis drug could prevent disease
A drug used to treat rheumatoid arthritis could also prevent the disease in individuals deemed to be at risk. Results from a Phase 2b clinical trial, published in The Lancet by researchers led by King's College London, provides hope for arthritis sufferers after it was shown that the biologic drug abatacept reduces progression to this agonising chronic inflammatory disease. (Source: World Pharma News)
Source: World Pharma News - February 14, 2024 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Trial offers hope for millions that jab could prevent rheumatoid arthritis
An existing drug for the chronic disease could slow or stop its progression, researchers sayScientists have discovered a jab that could prevent rheumatoid arthritis (RA), a development experts say could offer hope to millions at risk of the disease.RA is a chronic disease that causes inflammation in the body and triggers pain in the joints. About 18 million people globally are affected by the condition, which can lead to heart, lung or nervous system problems, according to the World Health Organization.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - February 13, 2024 Category: Science Authors: Andrew Gregory Health editor Tags: Health Science Medical research Society UK news World news Source Type: news

Study: Acupuncture could reduce stroke risk in people with rheumatoid arthritis
People with rheumatoid arthritis have an increased risk of stroke, but a new study indicates that acupuncture could reduce that risk. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 13, 2024 Category: Consumer Health News Source Type: news